Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Tam

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|September 24, 2004
Oligothiophene isocyanides for platinum-based molecular electronic applicationsDennis Bong, Iris Tam, Ronald Breslow
The American Journal of Managed Care|February 14, 2023
Evolving considerations for choice of hepatitis B vaccineDalga D Surofchy, Neil Shieh, Iris Tam
Organic Letters|September 12, 2003
A forbidden rearrangementMartin Leivers, Iris Tam, Kevin Groves, et al.
Journal of Managed Care & Specialty Pharmacy|August 28, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye diseaseDarrell E White, Laura H Hendrix, Lucille Sun, et al.
Journal of Managed Care & Specialty Pharmacy|June 10, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye diseaseDenise M Visco, Laura H Hendrix, Lucille Sun, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|September 24, 2004
Oligothiophene isocyanides for platinum-based molecular electronic applicationsDennis Bong, Iris Tam, Ronald Breslow
The American Journal of Managed Care|February 14, 2023
Evolving considerations for choice of hepatitis B vaccineDalga D Surofchy, Neil Shieh, Iris Tam
Organic Letters|September 12, 2003
A forbidden rearrangementMartin Leivers, Iris Tam, Kevin Groves, et al.
Journal of Managed Care & Specialty Pharmacy|August 28, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye diseaseDarrell E White, Laura H Hendrix, Lucille Sun, et al.
Journal of Managed Care & Specialty Pharmacy|June 10, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye diseaseDenise M Visco, Laura H Hendrix, Lucille Sun, et al.
Pageof 1